Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,396 public trials 842 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

NCT01465659

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +15 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Feasibility of a Mobile Medication Plan Application in CF Patient Care

NCT03637504

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis in Children, +6 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • University of Arizona and Banner Health Tucson, Arizona, United States
  • Lucille Packard Children's Hospital Stanford Stanford, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

NCT02709109

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Little Rock, Arkansas, United States
  • Oakland, California, United States
  • Gainesville, Florida, United States
  • Miami, Florida, United States
View all 40 locations
View Trial Details
Completed

Cystic Fibrosis Adherence Study

NCT04217889

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Centre de Référence de la Mucoviscidose Lyon à l'hôpital Lyon Sud Pierre-Bénite, France
View Trial Details
Completed

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

NCT02343445

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Univ of Florida Dept of Medicine Gainesville, Florida, United States
  • University of Miami Adult CF Center Miami, Florida, United States
  • Central Florida Pulmonary Group, PA Orlando, Florida, United States
View all 33 locations
View Trial Details
Completed

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

NCT03098550

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Pacific Shores Medical Group Long Beach, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University Of Michigan Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details

Related conditions